Subscribe
Sign in
Home
Podcast
Kidneyverse
News
Data Room 📊
Careers
Sponsors
Archive
Latest
Top
Discussions
What Kidney Week tells us about 2025
Drugs and devices take center stage, while VBC takes a back seat
Nov 18
Â
•
Â
Tim Fitzpatrick
1
Share this post
Signals From [Space]
What Kidney Week tells us about 2025
Copy link
Facebook
Email
Notes
More
1
Expert Q&A: Device Innovation in Kidney Failure (ESKD/AKI)
How 6 experts think about progress, pitfalls, and potential in this space
Nov 15
Â
•
Â
Tim Fitzpatrick
,Â
John E Milad
,Â
David Narrow
,Â
Michael Serle DMSc., MS, PA-C
,Â
Cynthia Silva, MD
,Â
Alex Hassan
, andÂ
Eric Schlorff
1
Share this post
Copy link
Facebook
Email
Notes
More
16:04
Expert Q&A: Value-Based Kidney Care
How 6 experts think about progress, pitfalls, and potential in this space
Nov 10
Â
•
Â
Tim Fitzpatrick
1
Share this post
Copy link
Facebook
Email
Notes
More
2
22:38
[Audio] Signals Weekly: November 7, 2024
Baxter restarts North Cove; CMS delays IOTA; IgAN at Kidney Week; Sonavex gets $15M; & more...
Nov 7
Â
•
Â
Tim Fitzpatrick
Share this post
Copy link
Facebook
Email
Notes
More
2
22:27
Signals Weekly: Baxter restarts North Cove; CMS delays IOTA; IgAN at Kidney Week; Sonavex gets $15M; & more...
Your weekly collection of news, research, funding & community voices shaping the future of kidney care.
Nov 4
Â
•
Â
Tim Fitzpatrick
6
Share this post
Signals From [Space]
Signals Weekly: Baxter restarts North Cove; CMS delays IOTA; IgAN at Kidney Week; Sonavex gets $15M; & more...
Copy link
Facebook
Email
Notes
More
Part 04: Why should physicians care about costs? | Eugene Lin, MD (Nephrologist, Researcher)
"I do think that fee-for-service medicine really has been a poison pill for physicians."
Nov 1
Â
•
Â
Tim Fitzpatrick
,Â
Lilian Okonkwo
, andÂ
Alice Wei, MD
3
Share this post
Signals From [Space]
Part 04: Why should physicians care about costs? | Eugene Lin, MD (Nephrologist, Researcher)
Copy link
Facebook
Email
Notes
More
5:58
October 2024
DHNY Summit 2024: Why The Big Apple is Leading Digital Health Innovation
“It was clear from the expertise and quality of attendees that NYC is a key hub for both current and next generation healthcare innovation and…
Oct 21
Â
•
Â
Alice Wei, MD
 andÂ
Tim Fitzpatrick
1
Share this post
Signals From [Space]
DHNY Summit 2024: Why The Big Apple is Leading Digital Health Innovation
Copy link
Facebook
Email
Notes
More
Part 03: What's the role of policy in VBC? Is VBC here to stay? | Eugene Lin, MD (Nephrologist, Researcher)
"We know that the value-based care train has already left the station, and policymakers on both sides of the aisle broadly want this to happen."
Oct 15
Â
•
Â
Tim Fitzpatrick
,Â
Lilian Okonkwo
, andÂ
Alice Wei, MD
2
Share this post
Signals From [Space]
Part 03: What's the role of policy in VBC? Is VBC here to stay? | Eugene Lin, MD (Nephrologist, Researcher)
Copy link
Facebook
Email
Notes
More
2
12:29
Signals Weekly: Supply chain struggles, new biotech funding, novel gene therapy progress, and a sister’s life-saving kidney donation; …
Your weekly collection of news, research, funding & community voices shaping the future of kidney care.
Oct 14
Â
•
Â
Tim Fitzpatrick
1
Share this post
Signals From [Space]
Signals Weekly: Supply chain struggles, new biotech funding, novel gene therapy progress, and a sister’s life-saving kidney donation; & more...
Copy link
Facebook
Email
Notes
More
Health Insurers Are Using Venture Capital Investments To Expand Their Reach
Health insurance companies are aggressively expanding to adjacent markets and services, a strategy that has led insurers to make venture investments in…
Published on HEALTH CARE un-covered
Â
•
Â
Oct 10
Mahesh Krishnan on ESRD policy reform, funding innovation, and the evolution of kidney care delivery
"Ultimately, this journey shaped my belief that to drive real change in care delivery, you need to work on the system level, influencing policy…
Oct 8
Â
•
Â
Tim Fitzpatrick
 andÂ
Jcnaeve
1
Share this post
Signals From [Space]
Mahesh Krishnan on ESRD policy reform, funding innovation, and the evolution of kidney care delivery
Copy link
Facebook
Email
Notes
More
Signals Weekly: Helene's dialysis toll; KCC results are in; Humana MA ratings cut; Mendaera's $73M Series B; & More...
Your weekly collection of news, research, funding & community voices shaping the future of kidney care.
Oct 6
Â
•
Â
Tim Fitzpatrick
Share this post
Signals From [Space]
Signals Weekly: Helene's dialysis toll; KCC results are in; Humana MA ratings cut; Mendaera's $73M Series B; & More...
Copy link
Facebook
Email
Notes
More
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts